Engrave Wealth Partners LLC Amgen Inc Transaction History

Engrave Wealth Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $158,623 - $176,402	-676 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $9,297 - $11,408	47 Added 7.47%	676 $159,000
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $4,556 - $6,042	25 Added 4.14%	629 $127,000
Q4 2019 Mar 12, 2020	BUY	$189.21 - $243.2 $114,282 - $146,892	604 New	604 $145,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Engrave Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Engrave Wealth Partners LLC with notifications on news.